Financiere des Professionnels - Fonds d'investissement inc.
Position in LLY — ELI LILLY & Co
CIK 1996846
MONTREAL, A8
Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$9,468,301
+$2,266,503 QoQ
Shares Held
7,894
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#1,295
of 4,605 holders
Holding Since
Sep 2025
4 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financiere des Professionnels - Fonds d'investissement inc. holds $56,644,054 across 7 Drug Manufacturers - General names. LLY ranks #4 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
58,412 | $14,698,795 | |
| 2 | JNJ |
Johnson & Johnson
|
51,324 | $13,034,755 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,117 | $11,965,534 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
7,894 | $9,468,301 | |
| 5 | PFE |
Pfizer Inc
|
201,100 | $4,842,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,638 | $2,354,724 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,850 | $279,457 |
All Filings in LLY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,468,301 | 7,894 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $7,201,798 | 7,830 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,351,947 | 1,258 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $959,854 | 1,258 | Shares | Defined | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||